Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Larissa Balogh Endocrine Laboratory California State University at Long Beach PowerPoint Presentation
Download Presentation
Larissa Balogh Endocrine Laboratory California State University at Long Beach

Larissa Balogh Endocrine Laboratory California State University at Long Beach

478 Views Download Presentation
Download Presentation

Larissa Balogh Endocrine Laboratory California State University at Long Beach

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. The Growth Inhibitory Role and Cell Membrane Association of a Reptilian Insulin-Like Growth Factor Binding Protein Larissa Balogh Endocrine Laboratory California State University at Long Beach Research Advisor: Dr. Kevin M. Kelley

  2. Insulin-like growth factors • Insulin-like growth factors (IGFs) are growth-stimulatory peptides • IGF-I receptor activates cell growth • Insulin receptor transduces metabolic functions

  3. INS/IGF Precursor (before vertebrate emergence) IGFBP introduced (early vertebrates?) INS IGF X ? IGFBP Cell Membrane INS-Receptor IGF-Receptor (metabolic) (growth) Slide by Dr. Kevin Kelley

  4. IGF-binding proteins • IGF-binding proteins (IGFBPs) are the integrators of the endocrine growth-regulatory apparatus • block IGF interaction with insulin receptors • regulate IGF bioactivity • IGF-independent effects

  5. Six principal mammalian IGFBPs • Little is known about non-mammalian IGFBPs • IgH-2 cell line • derived from heart epithelial cells • of the reptile, Iguana iguana

  6. IgH-2 Iguana heart cell • single IGFBP, binds 125I-IGF-I • binds cell membrane surface • removal of cell-surface IGFBP Photo by Dr. Underwood, CSULB using a Nikon E800 microscope with a magnifier CCD camera

  7. Hypothesis • The membrane-bound Iguana IGFBP serves an IGF-inhibitory role in the heart cells IGF arriving at the cellular site is removed from proximity to the growth receptor

  8. cell surface IGFBP IGF-I receptor

  9. Goals • Determine the effects of IGF-I on cell-surface associated IGFBP (without potential IGF activation of IGF receptor signaling) • Determine the effects of the IGFBP on the cells mitogenic response to IGF-I • Establish if the Iguana IGFBP cell-surface associates by utilizing a RGD sequence

  10. IGF-I analogs [Ala31][Leu60]IGF-I Des(1-3)IGF-I IGF-I Cell surface IGFBP IGF-I receptor

  11. Materials and Methods IgH-2 cells Time and dose dependent removal of IGFBP IGF-I [Ala31][Leu60]IGF-I Des(1-3)IGF-I Affinity cross-linking of cell monolayer Western Ligand Blot of treatment media

  12. Materials and Methods Effects of the IGFBP on the cells mitogenic response to IGF-I Thymidine Incorporation assay • Two subsets of cells “ IGFBP present” and “IGFBP removed” • Treatment with IGF-I or Des(1-3)IGF-I • Addition of [3H]thymidine • Counted on LSC

  13. Materials and Methods IgH-2 cells Competitive inhibition of IGFBP cell membrane binding GRGDSP synthetic peptide GRGESP synthetic peptide Western Ligand Blot of treatment media Affinity cross-linking of cell monolayer

  14. Results • Time and dose dependent removal of the IGFBP from the cell surface

  15. 15 minute incubation with [Ala31][Leu60]IGF-I 0 1nM 3nM 0.1M 1M IGF Des IGF receptor (135 kDa) IGFBP bound with 125I-IGF-I (37 kDa) Released IGFBP (30 kDa) Rat Serum

  16. Results • Effect of the IGFBP on the cells mitogenic response to IGF-I

  17. Thymidine incorporation 1

  18. Results • Competitive inhibition of IGFBP cell surface association by a RGD synthetic peptide

  19. GRGDSP (M) RGE 0 25 50 100 500 IGF IGF receptor (135 kDa) IGFBP bound with 125I-IGF-I (37 kDa) Released IGFBP (30 kDa) Rat Serum

  20. Conclusions • IgH-2 IGFBP removal from the cell surface by IGF-I is time and dose dependent, but independent of IGF-I activation of receptor signaling functions to inhibit IGF-I growth stimulation cell surfaces associates through a RGD amino acid sequence • Future research will be directed towards the cloning of this IGFBP

  21. Acknowledgments I would like to thank: - Dr. Kevin Kelley, Kathleen Sak, Kameron Schmidt, and all the other members of the CSULB Endocrine Lab - Howard Hughes Medical Institute